BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9386466)

  • 1. From darkness with courage...
    Aldridge R
    Nurs N Z; 1997 Oct; 3(9):21-2. PubMed ID: 9386466
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quality of life of schizophrenic patients and clozapine].
    Raoul Y; Manesse P; Delage M
    Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health education needs of people with schizophrenia taking clozapine.
    Gray R; Smedley N; Miller K; Vearnals S
    J Clin Nurs; 1996 Sep; 5(5):333-4. PubMed ID: 8932035
    [No Abstract]   [Full Text] [Related]  

  • 4. Interpretation of analysis.
    Heller JG
    Can J Clin Pharmacol; 2002; 9(3):129, 153; author reply 153. PubMed ID: 12474874
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new hope for schizophrenics: efficacy of a new drug.
    Marimuthu C; Prashanth ; Prabhakaran K
    Nurs J India; 1996 Jul; 87(7):149-51. PubMed ID: 8998043
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics.
    Strejilevich SA; Palatnik A; Avila R; Bustin J; Cassone J; Figueroa S; Gimenez M; de Erausquin GA
    Psychiatry Res; 2005 Feb; 133(2-3):277-80. PubMed ID: 15741003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
    Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
    J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
    Oh PI; Iskedjian M; Addis A; Lanctôt K; Einarson TR
    Can J Clin Pharmacol; 2001; 8(4):199-206. PubMed ID: 11743592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory schizophrenia: what works pharmacologically?
    Sousa S
    J Psychosoc Nurs Ment Health Serv; 1999 Feb; 37(2):19-23. PubMed ID: 10023603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clozapine in the treatment of under-age schizophrenia].
    Haapasalo-Pesu KM
    Duodecim; 2009; 125(15):1635-8. PubMed ID: 19769179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory schizophrenia treated with clozapine combined with zuclopenthixol.
    Cubała WJ; Wichowicz HM; Landowski J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):781-3. PubMed ID: 17258371
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model.
    Wang PS; Ganz DA; Benner JS; Glynn RJ; Avorn J
    J Ment Health Policy Econ; 2004 Jun; 7(2):77-85. PubMed ID: 15208468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clozapine in the treatment of schizophrenia].
    Raitasuo V
    Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005
    [No Abstract]   [Full Text] [Related]  

  • 17. Facilitating compliance with antipsychotic medication.
    Marder SR
    J Clin Psychiatry; 1998; 59 Suppl 3():21-5. PubMed ID: 9541334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs].
    Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G
    Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.
    Zink M; Mase E; Dressing H
    Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.